These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17009223)

  • 1. Antimalarial agents: closing the gate on Toll-like receptors?
    Lafyatis R; York M; Marshak-Rothstein A
    Arthritis Rheum; 2006 Oct; 54(10):3068-70. PubMed ID: 17009223
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimalarial agents and lupus.
    Wallace DJ
    Rheum Dis Clin North Am; 1994 Feb; 20(1):243-63. PubMed ID: 8153401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do Toll-like receptors contribute to the pathogenesis of lupus?
    Youinou P
    J Rheumatol; 2007 Aug; 34(8):1641-2. PubMed ID: 17696280
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of functional interleukin 10/tumor necrosis factor-alpha polymorphisms on interferon-alpha, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment.
    López P; Gómez J; Prado C; Gutiérrez C; Suárez A
    J Rheumatol; 2008 Aug; 35(8):1559-66. PubMed ID: 18597405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antimalarial agents on fasting lipid profile in systemic lupus erythematosus.
    Capell HA
    J Rheumatol; 2001 Jul; 28(7):1742. PubMed ID: 11469495
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antimalarials in lupus erythematosus treatment].
    Woźniacka A
    Przegl Lek; 2002; 59(3):179-82. PubMed ID: 12184034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antimalarial drugs in contemporary dermatologic therapy].
    Kiedrowicz M; Kacalak-Rzepka A; Bielecka-Grzela S; Maleszka R
    Ann Acad Med Stetin; 2011; 57(1):38-44. PubMed ID: 22593989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New concepts in antimalarial use and mode of action in dermatology.
    Kalia S; Dutz JP
    Dermatol Ther; 2007; 20(4):160-74. PubMed ID: 17970883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mode of action of hydroxychloroquine in RA-evidence of an inhibitory effect on toll-like receptor signaling.
    Kyburz D; Brentano F; Gay S
    Nat Clin Pract Rheumatol; 2006 Sep; 2(9):458-9. PubMed ID: 16951696
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydroxychloroquine blood assay as a marker of nonadherence in patients with systemic lupus erythematosus: comment on the article by Koneru et al.
    Costedoat-Chalumeau N; Amoura Z; Marra D; Piette JC
    Arthritis Rheum; 2008 Jan; 59(1):153; author reply 153-4. PubMed ID: 18163410
    [No Abstract]   [Full Text] [Related]  

  • 11. An update on pathogenesis of systemic lupus erythematosus.
    Ahmadpoor P; Dalili N; Rostami M
    Iran J Kidney Dis; 2014 May; 8(3):171-84. PubMed ID: 24878938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimalarial drugs, pregnancy and lactation.
    Parke AL
    Lupus; 1993 Feb; 2 Suppl 1():S21-3. PubMed ID: 8485567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus.
    Costedoat-Chalumeau N; Amoura Z; Hulot JS; Hammoud HA; Aymard G; Cacoub P; Francès C; Wechsler B; Huong du LT; Ghillani P; Musset L; Lechat P; Piette JC
    Arthritis Rheum; 2006 Oct; 54(10):3284-90. PubMed ID: 17009263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimalarial drug-induced aquagenic-type pruritus in patients with lupus.
    Jiménez-Alonso J; Tercedor J; Jáimez L; García-Lora E
    Arthritis Rheum; 1998 Apr; 41(4):744-5. PubMed ID: 9550488
    [No Abstract]   [Full Text] [Related]  

  • 15. Systemic lupus erythematosus IX: nonsteroidal anti-inflammatory drugs and antimalarial agents.
    Schmidt MC
    Md State Med J; 1984 Apr; 33(4):296-8. PubMed ID: 6727438
    [No Abstract]   [Full Text] [Related]  

  • 16. [Eye toxicity of antimalarial agents].
    Graña Gil J; Cabana Vázquez M; Vázquez González A; Sánchez Meizoso MO
    An Med Interna; 2002 Apr; 19(4):189-91. PubMed ID: 12090061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxychloroquine: the cornerstone of lupus therapy.
    Ruiz-Irastorza G; Khamashta MA
    Lupus; 2008 Apr; 17(4):271-3. PubMed ID: 18413405
    [No Abstract]   [Full Text] [Related]  

  • 18. Factors associated with blood hydroxychloroquine level in lupus patients: renal function could be important.
    Lee JY; Luc S; Greenblatt DJ; Kalish R; McAlindon TE
    Lupus; 2013 Apr; 22(5):541-2. PubMed ID: 23396569
    [No Abstract]   [Full Text] [Related]  

  • 19. Thrombovascular events in systemic lupus erythematosus: comment on the article by Jung et al.
    Wallace DJ
    Arthritis Rheum; 2010 Sep; 62(9):2824; author reply 2824-5. PubMed ID: 20872599
    [No Abstract]   [Full Text] [Related]  

  • 20. A bridge between interferon-alpha and tumor necrosis factor in lupus.
    Aringer M; Crow MK
    J Rheumatol; 2008 Aug; 35(8):1473-6. PubMed ID: 18671317
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.